Establishment Labs Holdings Stock Current Liabilities
| ESTA Stock | USD 45.89 0.18 0.39% |
Establishment Labs Holdings fundamentals help investors to digest information that contributes to Establishment Labs' financial success or failures. It also enables traders to predict the movement of Establishment Stock. The fundamental analysis module provides a way to measure Establishment Labs' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Establishment Labs stock.
The current year's Non Current Liabilities Total is expected to grow to about 202.8 M, whereas Total Current Liabilities is forecasted to decline to about 30.6 M. Establishment | Current Liabilities |
Establishment Labs Holdings Company Current Liabilities Analysis
Establishment Labs' Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current Establishment Labs Current Liabilities | 45.78 M |
Most of Establishment Labs' fundamental indicators, such as Current Liabilities, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Establishment Labs Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Establishment Current Liabilities Driver Correlations
Understanding the fundamental principles of building solid financial models for Establishment Labs is extremely important. It helps to project a fair market value of Establishment Stock properly, considering its historical fundamentals such as Current Liabilities. Since Establishment Labs' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Establishment Labs' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Establishment Labs' interrelated accounts and indicators.
Click cells to compare fundamentals
Establishment Current Liabilities Historical Pattern
Today, most investors in Establishment Labs Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Establishment Labs' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current liabilities growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Establishment Labs current liabilities as a starting point in their analysis.
Establishment Labs Current Liabilities |
| Timeline |
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
| Competition |
Establishment Total Current Liabilities
Total Current Liabilities |
|
In accordance with the recently published financial statements, Establishment Labs Holdings has a Current Liabilities of 45.78 M. This is 97.39% lower than that of the Health Care Equipment & Supplies sector and 93.53% lower than that of the Health Care industry. The current liabilities for all United States stocks is 99.42% higher than that of the company.
Establishment Current Liabilities Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Establishment Labs' direct or indirect competition against its Current Liabilities to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Establishment Labs could also be used in its relative valuation, which is a method of valuing Establishment Labs by comparing valuation metrics of similar companies.Establishment Labs is currently under evaluation in current liabilities category among its peers.
Establishment Labs Current Valuation Drivers
We derive many important indicators used in calculating different scores of Establishment Labs from analyzing Establishment Labs' financial statements. These drivers represent accounts that assess Establishment Labs' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Establishment Labs' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 568.2M | 877.6M | 1.6B | 1.6B | 662.8M | 706.4M | |
| Enterprise Value | 578.7M | 844.9M | 1.6B | 1.7B | 815.0M | 732.2M |
Establishment Labs ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Establishment Labs' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Establishment Labs' managers, analysts, and investors.Environmental | Governance | Social |
Establishment Fundamentals
| Return On Equity | -2.23 | ||||
| Return On Asset | -0.12 | ||||
| Profit Margin | (0.46) % | ||||
| Operating Margin | (0.33) % | ||||
| Current Valuation | 1.48 B | ||||
| Shares Outstanding | 28.76 M | ||||
| Shares Owned By Insiders | 11.27 % | ||||
| Shares Owned By Institutions | 98.62 % | ||||
| Number Of Shares Shorted | 4.94 M | ||||
| Price To Earning | (20.11) X | ||||
| Price To Book | 40.51 X | ||||
| Price To Sales | 8.62 X | ||||
| Revenue | 165.15 M | ||||
| Gross Profit | 106.59 M | ||||
| EBITDA | (58.31 M) | ||||
| Net Income | (78.5 M) | ||||
| Cash And Equivalents | 65.35 M | ||||
| Cash Per Share | 2.68 X | ||||
| Total Debt | 192.22 M | ||||
| Current Ratio | 4.27 X | ||||
| Book Value Per Share | 1.16 X | ||||
| Cash Flow From Operations | (88.51 M) | ||||
| Short Ratio | 11.02 X | ||||
| Earnings Per Share | (2.59) X | ||||
| Target Price | 60.29 | ||||
| Number Of Employees | 908 | ||||
| Beta | 1.21 | ||||
| Market Capitalization | 1.32 B | ||||
| Total Asset | 268.64 M | ||||
| Retained Earnings | (360.1 M) | ||||
| Working Capital | 117.75 M | ||||
| Current Asset | 60.91 M | ||||
| Current Liabilities | 45.78 M | ||||
| Net Asset | 268.64 M |
About Establishment Labs Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Establishment Labs Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Establishment Labs using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Establishment Labs Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Establishment Labs offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Establishment Labs' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Establishment Labs Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Establishment Labs Holdings Stock:Check out Establishment Labs Piotroski F Score and Establishment Labs Altman Z Score analysis. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Establishment Labs. If investors know Establishment will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Establishment Labs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.59) | Revenue Per Share 5.58 | Quarterly Revenue Growth 0.045 | Return On Assets (0.12) | Return On Equity (2.23) |
The market value of Establishment Labs is measured differently than its book value, which is the value of Establishment that is recorded on the company's balance sheet. Investors also form their own opinion of Establishment Labs' value that differs from its market value or its book value, called intrinsic value, which is Establishment Labs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Establishment Labs' market value can be influenced by many factors that don't directly affect Establishment Labs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Establishment Labs' value and its price as these two are different measures arrived at by different means. Investors typically determine if Establishment Labs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Establishment Labs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.